| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
73,830,000 |
| Market
Cap: |
3.78(B) |
| Last
Volume: |
581,366 |
Avg
Vol: |
694,871 |
| 52
Week Range: |
$39.75 - $67.51 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Semiconductor Equipment & Materials |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ COMPUTER |
|
S&P SMALLCAP 600 |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 443 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Azenta provides life science sample exploration and management solutions. Co.'s segments are: Life Sciences Products, which provides automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling, consumables, and instruments; and Life Sciences Services, which provides sample management programs, cold chain solutions, informatics, as well as sample-based laboratory services, including sample storage, genomic sequencing, gene synthesis, laboratory processing services, laboratory analysis, biospecimen procurement services and other support services to scientific research and support drug development.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
12,975 |
| Total Buy Value |
$0 |
$0 |
$0 |
$752,191 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
0 |
39,197 |
39,197 |
| Total Sell Value |
$0 |
$0 |
$2,183,306 |
$2,183,306 |
| Total People Sold |
0 |
0 |
2 |
2 |
| Total Sell Transactions |
0 |
0 |
5 |
5 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Tenney Maurice H. |
President-Brooks Life Sciences |
• – – |
2017-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
7,678 |
192,685 |
|
- |
|
| Schwartz Stephen S |
CEO |
• • – |
2017-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
18,402 |
664,074 |
|
- |
|
| Gray David C |
Chief Strategy & New Business |
• – – |
2017-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,565 |
105,282 |
|
- |
|
| Joseph Jason |
VP, General Counsel, Secretary |
• – – |
2017-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,565 |
125,722 |
|
- |
|
| Pietrantoni David |
Principal Accounting Officer |
• – – |
2017-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,449 |
71,311 |
|
- |
|
| Montone William T. |
SVP, Human Resources |
• – – |
2017-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
12,972 |
147,471 |
|
- |
|
| Robertson Lindon G |
EVP & Chief Financial Officer |
• – – |
2017-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
8,784 |
184,458 |
|
- |
|
| Jarzynka David |
Sr. VP, General Manager |
• – – |
2017-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
16,184 |
50,860 |
|
- |
|
| Joseph Jason |
VP, General Counsel, Secretary |
• – – |
2017-11-06 |
4 |
S |
$33.80 |
$76,287 |
D/D |
(2,257) |
121,157 |
|
- |
|
| Robertson Lindon G |
EVP & Chief Financial Officer |
• – – |
2017-11-06 |
4 |
S |
$33.80 |
$134,862 |
D/D |
(3,990) |
175,674 |
|
- |
|
| Jarzynka David |
Sr. VP, General Manager |
• – – |
2017-11-06 |
4 |
S |
$33.80 |
$83,689 |
D/D |
(2,476) |
34,676 |
|
- |
|
| Tenney Maurice H. |
President-Brooks Life Sciences |
• – – |
2017-11-06 |
4 |
S |
$33.80 |
$466,034 |
D/D |
(13,788) |
185,007 |
|
- |
|
| Gray David C |
Chief Strategy & New Business |
• – – |
2017-11-06 |
4 |
S |
$33.80 |
$80,917 |
D/D |
(2,394) |
100,717 |
|
- |
|
| Pietrantoni David |
Principal Accounting Officer |
• – – |
2017-11-06 |
4 |
S |
$33.80 |
$44,177 |
D/D |
(1,307) |
68,862 |
|
- |
|
| Schwartz Stephen S |
CEO |
• • – |
2017-11-06 |
4 |
S |
$33.80 |
$292,945 |
D/D |
(8,667) |
645,672 |
|
- |
|
| Montone William T. |
SVP, Human Resources |
• – – |
2017-11-06 |
4 |
S |
$33.80 |
$76,287 |
D/D |
(2,257) |
134,499 |
|
- |
|
| Joseph Jason |
VP, General Counsel, Secretary |
• – – |
2017-07-31 |
4 |
A |
$15.02 |
$5,753 |
D/D |
383 |
123,414 |
|
- |
|
| Robertson Lindon G |
EVP & Chief Financial Officer |
• – – |
2017-07-31 |
4 |
A |
$15.02 |
$11,040 |
D/D |
735 |
179,664 |
|
- |
|
| Pietrantoni David |
Principal Accounting Officer |
• – – |
2017-05-05 |
4 |
S |
$26.12 |
$30,482 |
D/D |
(1,167) |
70,169 |
|
- |
|
| Jarzynka David |
Sr. VP, General Manager |
• – – |
2017-05-05 |
4 |
S |
$26.12 |
$51,639 |
D/D |
(1,977) |
37,152 |
|
- |
|
| Robertson Lindon G |
EVP & Chief Financial Officer |
• – – |
2017-02-09 |
4 |
S |
$20.93 |
$984,066 |
D/D |
(47,017) |
178,929 |
|
- |
|
| Wrighton Mark S |
Director |
– • – |
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,355 |
99,157 |
|
- |
|
| Martin Joseph R |
Director |
– • – |
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,290 |
80,319 |
|
- |
|
| Zane Ellen M |
Director |
– • – |
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,355 |
42,185 |
|
- |
|
| Palepu Krishna G. |
Director |
– • – |
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,355 |
87,678 |
|
- |
|
1054 Records found
|
|
Page 17 of 43 |
|
|
0.09 (0.18%) 
